Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time

Authors
Koo, Tai YeonLee, Ju HanMin, Sang-IlLee, YongguKim, Myung SooHa, JongwonKim, Soon IlAhn, CurieKim, Yu SeunKim, JayounHuh, Kyu HaYang, Jaeseok
Issue Date
Jul-2021
Publisher
Elsevier B.V.
Keywords
desensitization; donor-specific antibody; HLA incompatible; kidney transplantation; waiting time
Citation
Kidney International, v.100, no.1, pp 206 - 214
Pages
9
Indexed
SCIE
SCOPUS
Journal Title
Kidney International
Volume
100
Number
1
Start Page
206
End Page
214
URI
https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/986
DOI
10.1016/j.kint.2021.01.027
ISSN
0085-2538
1523-1755
Abstract
HLA-incompatible living donor kidney transplantation (LDKT) is one of efforts to increase kidney transplantation opportunity for sensitized patients with kidney failure. However, there are conflicting reports for outcomes of HLA-incompatible kidney transplantation compared to patients who wait for HLA-compatible deceased donor kidney transplantation (DDKT) in the United States and United Kingdom. Waiting for an HLA-compatible DDKT is relatively disadvantageous in Korea, because the average waiting time is more than five years. To study this further, we compared outcomes of HLA-incompatible LDKT with those who wait for HLA-compatible DDKT in Korea. One hundred eighty nine patients underwent HLA-incompatible LDKT after desensitization between 2006 and 2018 in two Korean hospitals (42 with a positive complement-dependent cytotoxicity cross-match, 89 with a positive flow cytometric cross-match, and 58 with a positive donor-specific antibody with negative cross-match). The distribution of matched variables was comparable between the HLA-incompatible LDKT group and the matched control groups (waiting-list-only group; and the waiting-list-or-HLA-compatible-DDKT groups; 930 patients each). The HLA-incompatible LDKT group showed a significantly better patient survival rate compared to the waiting-list-only group and the waiting-list-or-HLA-compatible-DDKT groups. Furthermore, the HLA-incompatible LDKT group showed a significant survival benefit as compared with the matched groups at all strength of donor-specific antibodies. Thus, HLA-incompatible LDKT could have a survival benefit as compared with patients who were waitlisted for HLA-compatible DDKT or received HLA-compatible DDKT in Korea. This suggests that HLA-incompatible LDKT as a good option for sensitized patients with kidney failure in countries with prolonged waiting times for DDKT.
Files in This Item
Go to Link
Appears in
Collections
서울 의과대학 > 서울 내과학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Yong gu photo

Lee, Yong gu
COLLEGE OF MEDICINE (DEPARTMENT OF INTERNAL MEDICINE)
Read more

Altmetrics

Total Views & Downloads

BROWSE